{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:15:56Z","timestamp":1787318156255,"version":"build-2736575974"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"Supplement_A","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Myocardial infarction (MI) is an acute clinical manifestation ischaemic heart disease, which is the leading cause of death worldwide. Infections also have an important burden worldwide, with lower respiratory infections being the worldwide leading cause of death due to communicable diseases. The relationship of MI with viral respiratory infections (including influenza and SARS-CoV-2) as a trigger has been well documented with significant associations. These infections can lead to Type 1 MI, where inflammation and vascular dysfunction, as well as the increased prothrombotic environment lead to atherothrombosis. Type 2 MI may also occur due to an imbalance of oxygen\/blood supply and myocardial demand (hypoxaemia, fever, and tachycardia). The data from randomized controlled trials showing a potential benefit of influenza vaccination in coronary artery disease patients should not be ignored. This can be considered a further argument for the association of viral infections (influenza in particular) and MI.<\/jats:p>","DOI":"10.1093\/eurheartjsupp\/suac122","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T10:56:41Z","timestamp":1668164201000},"page":"A12-A16","source":"Crossref","is-referenced-by-count":22,"title":["Myocardial infarction and viral triggers: what do we know by now?"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-5673","authenticated-orcid":false,"given":"Daniel","family":"Caldeira","sequence":"first","affiliation":[{"name":"Faculdade de Medicina, Centro Cardiovascular da Universidade de Lisboa\u2014CCUL, CAML, Universidade de Lisboa , Lisboa , Portugal"},{"name":"Cardiology Department, Hospital Universit\u00e1rio de Santa Maria\u2014CHULN , Lisboa , Portugal"},{"name":"Faculdade de Medicina, Laboratory of Clinical Pharmacology and Therapeutics, Universidade de Lisboa , Av. Prof. Egas Moniz, 1649-028 Lisboa , Portugal"},{"name":"Faculdade de Medicina, Centro de Estudos de Medicina Baseada na Evid\u00eancia (CEMBE), Universidade de Lisboa , Lisboa , Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Nogueira-Garcia","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina, Centro Cardiovascular da Universidade de Lisboa\u2014CCUL, CAML, Universidade de Lisboa , Lisboa , Portugal"},{"name":"Cardiology Department, Hospital Universit\u00e1rio de Santa Maria\u2014CHULN , Lisboa , Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"key":"2023021516185813500_","author":"World Health Organization","year":"2020"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/CIRCULATIONAHA.110.968776","article-title":"Physical, psychological and chemical triggers of acute cardiovascular events: preventive strategies","volume":"124","author":"Mittleman","year":"2011","journal-title":"Circulation"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(10)62296-9","article-title":"Public health importance of triggers of myocardial infarction: a comparative risk assessment","volume":"377","author":"Nawrot","year":"2011","journal-title":"Lancet"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ehj.2017.03.003","article-title":"Acute triggers of myocardial infarction: a case-crossover study","volume":"69","author":"Ghiasmand","year":"2017","journal-title":"Egypt Heart J"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(97)11084-4","article-title":"Acute respiratory-tract infections and risk of first-time acute myocardial infarction","volume":"351","author":"Meier","year":"1998","journal-title":"Lancet"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1056\/NEJMoa041747","article-title":"Risk of myocardial infarction and stroke after acute infection or vaccination","volume":"351","author":"Smeeth","year":"2004","journal-title":"N Engl J Med"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/eurheartj\/ehm516","article-title":"Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database","volume":"29","author":"Clayton","year":"2007","journal-title":"Eur Heart J"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2307\/4580606","article-title":"Excess mortality from causes other than influenza and pneumonia during influenza epidemics","volume":"47","author":"Collins","year":"1932","journal-title":"Public Health Rep (1896\u20131970)"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/infdis\/jis628","article-title":"Excess mortality associated with influenza A and B virus in Hong Kong, 1998\u20132009","volume":"206","author":"Wu","year":"2012","journal-title":"J Infect Dis"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(09)70233-6","article-title":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review","volume":"9","author":"Warren-Gash","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJMra1808137","article-title":"Acute infection and myocardial infarction","volume":"380","author":"Musher","year":"2019","journal-title":"N Engl J Med"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3390\/jcm9061683","article-title":"Acute coronary syndromes and Covid-19: exploring the uncertainties","volume":"9","author":"Schiavone","year":"2020","journal-title":"J Clin Med"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1136\/heartjnl-2015-307691","article-title":"Acute myocardial infarction and influenza: a meta-analysis of case\u2013control studies","volume":"101","author":"Barnes","year":"2015","journal-title":"Heart"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/14760584.2019.1690459","article-title":"The association of influenza infection and vaccine with myocardial infarction: systematic review and meta-analysis of self-controlled case series","volume":"18","author":"Caldeira","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N Engl J Med"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.amjmed.2019.05.002","article-title":"Outcomes of acute myocardial infarction in patients with influenza and other viral respiratory infections","volume":"132","author":"Vejpongsa","year":"2019","journal-title":"Am J Med"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/imj.13377","article-title":"Triggering of acute myocardial infarction by respiratory infection","volume":"47","author":"Ruane","year":"2017","journal-title":"Intern Med J"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(21)00896-5","article-title":"Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study","volume":"398","author":"Katsoularis","year":"2021","journal-title":"Lancet"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/S0140-6736(21)02284-4","article-title":"COVID-19 and myocardial infarction","volume":"398","author":"Caldeira","year":"2021","journal-title":"Lancet"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.013","article-title":"Risk of stroke\/transient ischemic attack or myocardial infarction with herpes zoster: a systematic review and meta-analysis","volume":"26","author":"Zhang","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"e025874","DOI":"10.1136\/bmjopen-2018-025874","article-title":"Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis","volume":"9","author":"Eyawo","year":"2019","journal-title":"BMJ Open"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.CIR.103.1.45","article-title":"Prospective study of pathogen burden and risk of myocardial infarction or death","volume":"103","author":"Zhu","year":"2001","journal-title":"Circulation"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1161\/01.CIR.98.25.2796","article-title":"Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/01.CIR.102.19.2335","article-title":"Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults","volume":"102","author":"Siscovick","year":"2000","journal-title":"Circulation"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/infdis\/jiab364","article-title":"Human cytomegalovirus and risk of incident cardiovascular disease in United Kingdom Biobank","volume":"225","author":"Hamilton","year":"2022","journal-title":"J Infect Dis"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jacc.2005.01.054","article-title":"Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction","volume":"45","author":"Mauriello","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/CIRCRESAHA.116.304944","article-title":"Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size","volume":"116","author":"Mangold","year":"2015","journal-title":"Circ Res"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.thromres.2011.10.013","article-title":"Sepsis, thrombosis and organ dysfunction","volume":"129","author":"Semeraro","year":"2012","journal-title":"Thromb Res"},{"key":"2023021516185813500_","first-page":"150","article-title":"Endothelial dysfunction in sepsis","volume":"11","author":"Boisrame-Helms","year":"2013","journal-title":"Curr Vasc Pharmacol"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"e0132259","DOI":"10.1371\/journal.pone.0132259","article-title":"Gene expression profiles link respiratory viral infection, platelet response to aspirin, and acute myocardial infarction","volume":"10","author":"Rose","year":"2015","journal-title":"PLoS One"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jacc.2019.02.018","article-title":"Type 2 myocardial infarction: JACC review topic of the week","volume":"73","author":"Sandoval","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/14787210.2019.1689817","article-title":"Cardiovascular complications of acute respiratory infections: current research and future directions","volume":"17","author":"Davidson","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"e055755","DOI":"10.1136\/bmjopen-2021-055755","article-title":"Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis","volume":"12","author":"White","year":"2022","journal-title":"BMJ Open"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamacardio.2022.0043","article-title":"Characteristics and outcomes of type 2 myocardial infarction","volume":"7","author":"Coscia","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1503\/cmaj.091891","article-title":"Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study","volume":"182","author":"Siriwardena","year":"2010","journal-title":"CMAJ"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.vaccine.2010.12.017","article-title":"The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study","volume":"29","author":"Gwini","year":"2011","journal-title":"Vaccine"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.118.036788","article-title":"Influenza vaccine in heart failure: cumulative number of vaccinations, frequency, timing, and survival: a Danish Nationwide Cohort Study","volume":"139","author":"Modin","year":"2019","journal-title":"Circulation"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"424","DOI":"10.20344\/amp.6846","article-title":"Analysis of the Cochrane review: influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015;5:CD005050","volume":"28","author":"Caldeira","year":"2015","journal-title":"Acta Med Port"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tcm.2020.06.003","article-title":"The impact of influenza vaccination in patients with cardiovascular disease: an overview of systematic reviews","volume":"31","author":"Rodrigues","year":"2021","journal-title":"Trends Cardiovasc Med"},{"key":"2023021516185813500_","article-title":"Influenza vaccines for preventing cardiovascular disease","volume":"2015","author":"Clar","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2013.279206","article-title":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","volume":"310","author":"Udell","year":"2013","journal-title":"JAMA"},{"key":"2023021516185813500_","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.121.057042","article-title":"Influenza vaccination after myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"144","author":"Fr\u00f6bert","year":"2021","journal-title":"Circulation"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/25\/Supplement_A\/A12\/49200063\/suac122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/25\/Supplement_A\/A12\/49200063\/suac122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T16:29:45Z","timestamp":1678552185000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/25\/Supplement_A\/A12\/7036731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":45,"journal-issue":{"issue":"Supplement_A","published-online":{"date-parts":[[2023,2,14]]},"published-print":{"date-parts":[[2023,2,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartjsupp\/suac122","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,15]]},"published":{"date-parts":[[2023,2,14]]}}}